These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17609235)

  • 21. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gadolinium as an alternative contrast agent during cardiac catheterization in patient with iodine-induced hyperthyroidism.
    Matuszczyk A; Hahn S; Böse D; Eggebrecht H; Schmermund A; Quadbeck B; Wieneke H; Petersenn S; Janssen OE; Mann K
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):336-8. PubMed ID: 16868894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypersensitivity to contrast media and dyes.
    Brockow K; Sánchez-Borges M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):547-64, viii. PubMed ID: 25017677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
    Collier K; Schink C; Young AM; How K; Seckl M; Savage P
    J Oncol Pharm Pract; 2008 Mar; 14(1):51-5. PubMed ID: 18337441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media.
    Della-Torre E; Berti A; Yacoub MR; Guglielmi B; Tombetti E; Sabbadini MG; Voltolini S; Colombo G
    Eur Ann Allergy Clin Immunol; 2015 May; 47(3):77-85. PubMed ID: 25951145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of possible hypersensitivity to iodized contrast media and prophylactic measures].
    Sabbah A; Knoepfler PJ; Menard E
    Ann Radiol (Paris); 1969; 12(9):875-82. PubMed ID: 5371358
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amiodarone: a new cause of hypersensitivity pneumopathy?].
    Arlet P; Carré P; Bismuth JM; Larregain-Fournier D; Le Tallec Y
    Rev Pneumol Clin; 1984; 40(3):205-7. PubMed ID: 6463506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose.
    Sesé L; Gaouar H; Autegarden JE; Alari A; Amsler E; Vial-Dupuy A; Pecquet C; Francès C; Soria A
    Clin Exp Allergy; 2016 Mar; 46(3):472-8. PubMed ID: 26750091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hypersensitivity reactions to iodinated contrast media.
    Brockow K; Christiansen C; Kanny G; Clément O; Barbaud A; Bircher A; Dewachter P; Guéant JL; Rodriguez Guéant RM; Mouton-Faivre C; Ring J; Romano A; Sainte-Laudy J; Demoly P; Pichler WJ; ;
    Allergy; 2005 Feb; 60(2):150-8. PubMed ID: 15647034
    [No Abstract]   [Full Text] [Related]  

  • 33. Anaphylactic Shock as a Rare Side Effect of Intravenous Amiodarone.
    Batool A; Batool K; Habib H; Chaudhry S
    Cureus; 2022 Jan; 14(1):e21118. PubMed ID: 35165575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate reactions following iodinated contrast media injection: a study of 38 cases.
    Dewachter P; Laroche D; Mouton-Faivre C; Bloch-Morot E; Cercueil JP; Metge L; Carette MF; Vergnaud MC; Clément O
    Eur J Radiol; 2011 Mar; 77(3):495-501. PubMed ID: 19833466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
    Alves RJ; Geovanini GR; Brito Gd; Miguel GA; Glauser VA; Nakiri K
    Arq Bras Cardiol; 2007 Jul; 89(1):22-7. PubMed ID: 17768579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is interleukin-2 therapy still a risk factor for adverse reactions in concert with iodinated contrast medium injection?
    Boehm I
    Acta Radiol; 2009 Sep; 50(7):752-3. PubMed ID: 19629773
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal pseudo-obstruction caused by diltiazem in a neutropenic patient.
    Young RP; Wu H
    Ann Pharmacother; 2005 Oct; 39(10):1749-51. PubMed ID: 16144882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypersensitivity to iodinated contrast media].
    Zamacoma G; Talamantes S; Mejía Ortega J
    Alergia; 1972 May; 19(4):135-40. PubMed ID: 5072670
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III).
    Coleman CI; Kluger J; Dale K; Sander S; Gallagher R; Reinhart K; Henyan N; White CM
    Expert Opin Pharmacother; 2008 Jan; 9(1):7-13. PubMed ID: 18076334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.